TheraVet SA (ALVET.PA)
EUR 0.11
(-0.46%)
EUR 0.11
(-0.46%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | 1.07 Million | 1.6 Million | 1.94 Million | 987.8 Thousand | 780.64 Thousand |
| Cost of Revenue | 1.6 Million | 2.59 Million | 2.54 Million | 1.1 Million | 780.15 Thousand |
| Gross Profit | -530.79 Thousand | -992.8 Thousand | -603.55 Thousand | -112.2 Thousand | 486.00 |
| Operating Expenses | 1.64 Million | 1.78 Million | 1.12 Million | 288.99 Thousand | 95.81 Thousand |
| Selling, General and Administrative Expenses | -362.91 Thousand | -403.78 Thousand | -1.15 Million | -47.02 Thousand | 317.48 Thousand |
| Research and Development Expenses | 370.13 Thousand | 593.22 Thousand | 1.15 Million | 634.03 Thousand | - |
| Other Expenses | 1.63 Million | 1.78 Million | 1.12 Million | 288.99 Thousand | 95.81 Thousand |
| Cost and Expenses | 3.25 Million | 4.37 Million | 3.67 Million | 1.38 Million | 875.96 Thousand |
| Operating Income | -2.17 Million | -2.77 Million | -1.72 Million | -401.2 Thousand | -95.32 Thousand |
| Interest Expense | 24.26 Thousand | 30 Thousand | 26.45 Thousand | 24.89 Thousand | 7421.43 |
| Income Tax Expense | -45.76 Thousand | 13.59 Thousand | -126.97 Thousand | -490.00 | 507.21 |
| Earnings before Tax | -1.61 Million | -2.34 Million | -1.46 Million | -388.95 Thousand | -98.42 Thousand |
| Net Income | -1.57 Million | -2.36 Million | -1.34 Million | -388.46 Thousand | -98.93 Thousand |
| Earnings Per Share Basic | -0.49 | -0.73 | -0.42 | -0.12 | -0.03 |
| Earnings Per Share Diluted | -0.49 | -0.73 | -0.42 | -0.12 | -0.03 |
| Weighted Average Shares Outstanding | 3.22 Million | 3.22 Million | 3.22 Million | 3.22 Million | 3.22 Million |
| Weighted Average Shares Outstanding (Diluted) | 3.22 Million | 3.22 Million | 3.22 Million | 3.22 Million | 3.22 Million |
| Gross Margin | -0.49 | -0.62 | -0.31 | -0.11 | 0.00 |
| EBIT Margin | -0.48 | -0.89 | -0.45 | -0.32 | -0.11 |
| Profit Margin | -1.46 | -1.48 | -0.69 | -0.39 | -0.13 |
| EBITDA | -517.33 Thousand | -1.39 Million | -860.41 Thousand | -317.65 Thousand | -84.52 Thousand |
| Earnings Before Tax Margin | -2.02 | -1.73 | -0.89 | -0.41 | -0.12 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 225.2 Thousand | 225.2 Thousand | 117.83 Thousand | 233.95 Thousand | 233.95 Thousand | 55.26 Thousand |
| Cost of Revenue | 377.28 Thousand | 377.28 Thousand | 2.48 Million | 405.78 Thousand | 405.78 Thousand | 622.04 Thousand |
| Gross Profit | -152.07 Thousand | -152.07 Thousand | -2.36 Million | -171.83 Thousand | -171.83 Thousand | -566.78 Thousand |
| Operating Expenses | 330.05 Thousand | 330.05 Thousand | 7226.00 | 180.02 Thousand | 467.83 Thousand | 748.69 Thousand |
| Selling, General and Administrative Expenses | 161.17 Thousand | 161.17 Thousand | - | 164.4 Thousand | 164.4 Thousand | 542.37 Thousand |
| Research and Development Expenses | 45.05 Thousand | 45.05 Thousand | - | 81.91 Thousand | 81.91 Thousand | 206.31 Thousand |
| Other Expenses | 123.82 Thousand | 123.82 Thousand | 197.35 Thousand | - | - | - |
| Cost and Expenses | 707.33 Thousand | 707.33 Thousand | 2.49 Million | 585.81 Thousand | 873.62 Thousand | 1.37 Million |
| Operating Income | -482.13 Thousand | -482.13 Thousand | -2.37 Million | -427.97 Thousand | -427.97 Thousand | -1.31 Million |
| Interest Expense | 17.84 Thousand | - | 27.58 Thousand | - | - | 18.2 Thousand |
| Income Tax Expense | 174.82 Thousand | -22.12 Thousand | -45.76 Thousand | 22.88 Thousand | 22.88 Thousand | -2.00 |
| Earnings before Tax | -424.35 Thousand | -424.35 Thousand | -1.61 Million | -355.65 Thousand | -355.65 Thousand | -905.15 Thousand |
| Net Income | -424.35 Thousand | -424.35 Thousand | -1.57 Million | -332.77 Thousand | -332.77 Thousand | -905.15 Thousand |
| Earnings Per Share Basic | -0.13 | -0.13 | - | -0.10 | -0.10 | -0.28 |
| Earnings Per Share Diluted | -0.13 | -0.13 | - | -0.10 | -0.10 | -0.28 |
| Weighted Average Shares Outstanding | 3.22 Million | 3.22 Million | 3.22 Million | 3.22 Million | 3.22 Million | 3.22 Million |
| Weighted Average Shares Outstanding (Diluted) | 3.22 Million | 3.22 Million | 3.22 Million | 3.22 Million | 3.22 Million | 3.22 Million |
| Gross Margin | -0.68 | -0.68 | -20.07 | -0.73 | -0.73 | -10.26 |
| EBIT Margin | -1.40 | -1.40 | - | -1.60 | -1.02 | -11.38 |
| Profit Margin | -1.88 | -1.88 | -13.33 | -1.42 | -1.42 | -16.38 |
| EBITDA | -314.67 Thousand | -314.67 Thousand | - | -374.34 Thousand | -239.33 Thousand | -628.76 Thousand |
| Earnings Before Tax Margin | -2.14 | -2.14 | -20.13 | -1.83 | -1.83 | -23.80 |
PCIB
APLM
IDWM
CIE
603393
MEGACPO